Producing safe and highly effective anticancer therapies is only part of the new drug development equation, and ensuring patients’ access to them is equally, if not more, important for pharma companies operating in today’s environment.
As governments around the world, squeezed by ballooning medical expenditures, increase their scrutiny of drug prices, major manufacturers like
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?